NeueHealth (NYSE:NEUE) & Trupanion (NASDAQ:TRUP) Critical Survey

NeueHealth (NYSE:NEUEGet Free Report) and Trupanion (NASDAQ:TRUPGet Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Profitability

This table compares NeueHealth and Trupanion’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NeueHealth -71.23% N/A -1.21%
Trupanion -2.31% -9.10% -3.51%

Analyst Ratings

This is a breakdown of recent recommendations for NeueHealth and Trupanion, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeueHealth 0 1 0 0 2.00
Trupanion 0 3 2 0 2.40

NeueHealth presently has a consensus price target of $8.00, indicating a potential upside of 28.00%. Trupanion has a consensus price target of $29.40, indicating a potential upside of 48.11%. Given Trupanion’s stronger consensus rating and higher possible upside, analysts plainly believe Trupanion is more favorable than NeueHealth.

Earnings and Valuation

This table compares NeueHealth and Trupanion’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NeueHealth $1.16 billion 0.04 -$1.15 billion ($151.20) -0.04
Trupanion $1.11 billion 0.75 -$44.69 million ($0.64) -31.02

Trupanion has lower revenue, but higher earnings than NeueHealth. Trupanion is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

63.9% of NeueHealth shares are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 5.8% of Trupanion shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

NeueHealth has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500. Comparatively, Trupanion has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500.

Summary

Trupanion beats NeueHealth on 8 of the 14 factors compared between the two stocks.

About NeueHealth

(Get Free Report)

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.

About Trupanion

(Get Free Report)

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.